CAS 655236-28-5
:3-Quinolinecarboxylic acid, 8-bromo-5-fluoro-4-hydroxy-, ethyl ester
Description:
3-Quinolinecarboxylic acid, 8-bromo-5-fluoro-4-hydroxy-, ethyl ester is a chemical compound characterized by its quinoline structure, which is a bicyclic aromatic compound containing a nitrogen atom. This substance features several functional groups, including a carboxylic acid, an ester, and halogen substituents (bromo and fluoro), which can significantly influence its chemical reactivity and biological activity. The presence of the ethyl ester group suggests that it may exhibit properties typical of esters, such as being more lipophilic compared to its acid counterpart. The hydroxyl group contributes to potential hydrogen bonding capabilities, enhancing solubility in polar solvents. The bromine and fluorine substituents can affect the compound's electronic properties, potentially impacting its reactivity and interaction with biological targets. Overall, this compound may be of interest in medicinal chemistry and drug development due to its unique structural features and potential pharmacological properties.
Formula:C12H9BrFNO3
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
8-Bromo-5-fluoro-4-hydroxy-quinoline-3-carboxylic acid ethyl ester
CAS:Formula:C12H9BrFNO3Molecular weight:314.1072Ethyl 8-bromo-5-fluoro-4-hydroxyquinoline-3-carboxylate
CAS:<p>Ethyl 8-bromo-5-fluoro-4-hydroxyquinoline-3-carboxylate</p>Purity:≥95%Color and Shape:SolidMolecular weight:314.11g/molEthyl 8-bromo-5-fluoro-4-hydroxyquinoline-3-carboxylate
CAS:Ethyl 8-bromo-5-fluoro-4-hydroxyquinoline-3-carboxylate is a potent benzodiazepine receptor antagonist. It binds to the benzodiazepine receptor, preventing the binding of benzodiazepines and other drugs that act on this receptor. This drug has been shown to be a high affinity antagonist and has been successfully used in clinical trials for the treatment of anxiety disorders. The pharmacophore of ethyl 8-bromo-5-fluoro-4-hydroxyquinoline-3 -carboxylate is described by stepwise descriptor analysis, which identifies overlapping profiles with other benzodiazepine antagonists.Formula:C12H9BrFNO3Purity:Min. 95%Molecular weight:314.11 g/mol


